ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 115 filers reported holding ENZO BIOCHEM INC in Q3 2017. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $80,540,000 | +67016.7% | 14,697 | 0.0% | 0.00% | -50.0% |
| Q4 2017 | $120,000 | -62.4% | 14,697 | -51.8% | 0.00% | 0.0% |
| Q3 2017 | $319,000 | -9.1% | 30,469 | -4.3% | 0.00% | 0.0% |
| Q2 2017 | $351,000 | +32.0% | 31,831 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $266,000 | +19.3% | 31,831 | -1.1% | 0.00% | 0.0% |
| Q4 2016 | $223,000 | +36.0% | 32,184 | -0.3% | 0.00% | +100.0% |
| Q3 2016 | $164,000 | -15.5% | 32,289 | -0.8% | 0.00% | 0.0% |
| Q2 2016 | $194,000 | – | 32,556 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,736,719 | $9,414,000 | 13.61% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $17,805,000 | 8.40% |
| Evermore Global Advisors, LLC | 2,605,607 | $8,963,000 | 6.32% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $328,000 | 0.19% |
| CORRADO ADVISORS, LLC | 46,816 | $161,000 | 0.12% |
| MYDA Advisors LLC | 35,000 | $120,000 | 0.03% |
| Cutter & CO Brokerage, Inc. | 29,827 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 258,700 | $890,000 | 0.02% |
| Paradigm Financial Partners, LLC | 18,000 | $62,000 | 0.02% |
| Renaissance Technologies | 3,340,864 | $11,493,000 | 0.01% |